Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6,400 INR
Change Today +23.35 / 0.37%
Volume 2.7K
SKB On Other Exchanges
Symbol
Exchange
Natl India
As of 2:06 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
6,376
Previous Close
6,377
Day High
6,401
Day Low
6,307
52 Week High
04/15/15 - 6,575
52 Week Low
05/30/14 - 4,390
Market Cap
269.2B
Average Volume 10 Days
12.8K
EPS TTM
138.76
Shares Outstanding
42.1M
EX-Date
07/27/15
P/E TM
46.1x
Dividend
55.00
Dividend Yield
0.70%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. It manufactures and markets health food drinks, nutritional supplements, biscuits, and choco-malt drinks under the Horlicks, Boost, Maltova, and Viva brand names. The company also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, it provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. The company exports its products to Pakistan, Myanmar, Sri Lanka, Bangladesh, the Middle East, Nepal, Kenya, and Malaysia. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 97.4M
Director of Finance, Wholetime Director, Memb...
Total Annual Compensation: 36.7M
Director of Operations, Wholetime Director an...
Total Annual Compensation: 36.4M
Compensation as of Fiscal Year 2014.

glaxosmithkline consumer hea (SKB) Key Developments

Glaxosmithkline Consumer Healthcare Limited Recommends Dividend, Payable on or Before September 05, 2015

GlaxoSmithKline Consumer Healthcare Limited announced that the Board of Directors of the company at its meeting held on May 08, 2015, has recommended a Dividend at the rate of INR 55 per equity share of INR 10 each. The dividend shall be paid to the entitled Members on or before September 05, 2015.

GlaxoSmithKline Consumer Healthcare Limited Announces Unaudited Financial Results for the Fourth Quarter and Audited Financial Results for the Full Year Ended Mar. 31, 2015

GlaxoSmithKline Consumer Healthcare Limited announced unaudited financial results for the fourth quarter and audited financial results for the full year ended Mar. 31, 2015. For the quarter, the company reported profit from operations before other income, finance costs & exceptional items of INR 2,389 million against INR 2,219 million for the same period of last year. Profit from ordinary activities before tax was INR 2,982 million against INR 2,609.7 million for the same period of last year. Net profit for the period was INR 1,968 million or INR 46.79 per basic and diluted share against INR 1,717 million or INR 40.83 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 11,651 million against INR 10,791 million for the same period of last year. For the year, the company reported profit from operations before other income, finance costs & exceptional items of INR 6,679.9 million against INR 8,102 million for the same period of last year. Profit from ordinary activities before tax was INR 8,891 million against INR 10,161 million for the same period of last year. Net profit for the period was INR 5,836 million or INR 138.77 per basic and diluted share against INR 6,747 million or INR 160.44 per basic and diluted share for the same period of last year. Net sales/income from operations (net of excise duty) were INR 41,364 million against INR 46,829 million for the same period of last year.

GlaxoSmithkline Consumer Healthcare Ltd Announces Management Changes, Effective June 1, 2015

GlaxoSmithkline Consumer Healthcare Ltd. announced that Manoj Kumar has been appointed as the managing director of the company in place of Zubair Ahmed with effect from June 1, 2015, approved by the board of directors at its meeting held on May 8, 2015. The board had also appointed Vivek Anand as a Wholetime director and chief financial officer of the company, with effect from June 1, 2015, in the casual vacancy caused by the resignation of Mr. Ramakrishnan Subramanian, director - Finance. Ahmed and Subramanian have been appointed to the leadership team of Asia Pacific, Middle East and Africa operations of GSK Consumer Healthcare, as head of the region and vice president finance respectively. While in their new roles, Kumar will report into Ahmed and Anand will be reporting in to Subramanian. Ahmed and Subramanian will continue to guide them on matters pertaining to the listed entity.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 6,399.90 INR +23.35

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $3.99 USD -0.025
DC Brands International Inc $0.0002 USD 0.00
Perrigo Co PLC $193.96 USD -0.54
VIVUS Inc $2.51 USD -0.02
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 45.0x
Price/Sales 6.4x
Price/Book 12.4x
Price/Cash Flow 40.7x
TEV/Sales 5.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.